Catatonia Secondary to Depolarization Block
Omar H Elsayed1, Rif S El-Mallakh1
1Mood Disorders Research Program, Depression Center, Department of Psychiatry and Behavioral Sciences, University of Louisville School of Medicine, Louisville, KY 40202, USA.
Asian Journal of Psychiatry
|April 7, 2023
Summary
Catatonia, a severe psychomotor disorder, significantly increases premature death risk. It involves ion dysregulation, leading to neuronal depolarization block, which is effectively treated by hyperpolarizing neurons with benzodiazepines.
Area of Science:
- Neuroscience
- Psychiatry
- Cellular Biology
Background:
- Catatonia is a severe psychomotor disorder with a 60-fold increased risk of premature death.
- It is frequently associated with type I bipolar disorder and other psychiatric diagnoses.
- Catatonia is hypothesized to stem from ion dysregulation, specifically impaired intracellular sodium ion clearance.
Purpose of the Study:
- To elucidate the cellular mechanisms underlying catatonia.
- To explain the pathophysiology of catatonia as a state of neuronal depolarization block.
- To highlight the therapeutic implications of understanding catatonia's ion dysregulation basis.
Main Methods:
- Conceptual analysis of existing literature on catatonia pathophysiology.
- Explanation of ion transport mechanisms and neuronal membrane potential dynamics.
- Review of established and proposed treatment strategies for catatonia.
Main Results:
- Increased intracellular sodium concentration leads to elevated transmembrane potential.
- Sustained depolarization above the threshold potential results in a "depolarization block" in neurons.
- Neurons in depolarization block are tonically active but unresponsive to stimulation, mirroring catatonia symptoms.
Conclusions:
- Catatonia can be understood as a state of neuronal depolarization block caused by impaired sodium ion clearance.
- Hyperpolarization of neurons, achievable with benzodiazepines, represents the most effective treatment strategy.
- This mechanistic understanding offers a pathway for targeted therapeutic interventions in catatonia.
More Related Videos
08:11Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique
Published on: November 11, 2022
2.9K
09:39Direct-current Stimulation and Multi-electrode Array Recording of Seizure-like Activity in Mice Brain Slice Preparation
Published on: June 7, 2016
10.6K
Related Concept Videos
01:28Depolarizing Blockers: Mechanism of Action
1.7K
Depolarizing blockers act on skeletal muscle fibers' membranes and induce their depolarization. Most depolarizing blockers have two quaternary N+ atoms that bind the nicotinic acetylcholine receptors and cause neuromuscular blockade within minutes.
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
1.7K
01:19Depolarizing Blockers: Pharmocokinetics
355
Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
355
01:27Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
474
Nondepolarizing neuromuscular blockers prevent the membrane depolarization of muscle cells and inhibit muscle contraction. These are usually administered with anesthetics to achieve complete muscle relaxation. Upon administration, these drugs first block the small, rapidly contracting muscles of the face and hands, followed by the larger muscles of the trunk and the intercostal muscles. The diaphragm is the last muscle to be affected.
Although all competitive neuromuscular blockers are designed...
Although all competitive neuromuscular blockers are designed...
474
01:17Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
1.9K
Nondepolarizing neuromuscular blockers induce paralysis by competitively blocking nicotinic acetylcholine receptors at the muscle end plate. Examples include pancuronium, mivacurium, vecuronium, and rocuronium. These quaternary ammonium derivatives are administered intravenously, are poorly absorbed, and are excreted via the kidneys.
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
1.9K
01:30Cardiac Action Potential
1.9K
Cardiac action potentials are essential for proper heart function, enabling the rhythmic contractions needed for adequate blood circulation. Nodal cells and Purkinje fibers, specialized for electrical conduction, generate these action potentials.
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
The cardiac action potential process involves a series of phases characterized by the movement of ions across the cardiac cell membranes, leading to the depolarization and repolarization of the cardiac myocytes.
Ionic Basis of Cardiac Action Potentials
1.9K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.5K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.5K